| Financial Year |
March 31 2023 |
| Monetary Funds |
2,663,616,225.03 |
| Held-for-trading Financial Assets |
645,295,599.71 |
| Notes Receivable |
32,692,438.58 |
| Accounts Receivable |
1,767,978,510.65 |
| Advances to Suppliers |
398,293,500.71 |
| Other Receivables |
1,307,918,420.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
44,382,037.50 |
| Dividend Receivable |
31,000,000.00 |
| Inventories |
284,289,763.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
415,139,076.23 |
| Other Current Assets |
1,852,869,802.18 |
| Total Current Assets |
11,170,093,018.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
503,981,908.74 |
| Long-term Equity Investment |
3,608,113,353.82 |
| Investment Properties |
95,845,000,000.00 |
| Fixed Assetes |
2,558,333,388.67 |
| Under-construction Projects |
89,054,614.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,077,877.64 |
| R&D expenses |
12,522,655.66 |
| Goodwill |
97,597,047.85 |
| Long-Term Deferred and Prepaid Expenses |
404,206,119.33 |
| Deferred Income Tax Assets |
3,127,438,276.88 |
| Other Non-Current Assets |
4,417,028,601.86 |
| Sub-Total of Non-Current Assets |
116,480,969,437.97 |
| Total Assets |
127,651,062,456.68 |
| Short-Term Loans |
1,956,927,317.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
199,526,093.40 |
| Accounts Payable |
2,187,927,162.17 |
| Accounts Received In Advance |
718,205,235.02 |
| Employee Compensation Payable |
483,292,795.28 |
| Taxes Payable |
1,366,814,508.36 |
| Interest Payable |
-- |
| Dividend Payable |
31,936,071.16 |
| Other payables |
9,517,811,880.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,525,889,532.29 |
| Other Current Liabilities |
325,822,773.55 |
| Sub-Total of Current Liabilities |
24,848,681,151.19 |
| Long-term Loans |
22,280,792,127.64 |
| Bonds Payable |
1,701,582,501.22 |
| Long-Term Accounts Payable |
632,061,757.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,747,927,662.52 |
| Other Non-Current Liabilities |
3,817,884,073.68 |
| Sub-Total of Non-Current Liabilities |
45,555,718,257.00 |
| Total Liabilities |
70,404,399,408.19 |
| Paid-In Capital(Or Share Stock) |
4,354,732,673.00 |
| Capital Surplus |
6,877,299,502.09 |
| Surplus Reserve |
2,293,732,034.41 |
| LESS:Treasury Stock |
5,003,481.44 |
| Undistributed Profits |
39,223,499,964.65 |
| Minority Stockholder's Interest |
3,499,066,669.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,747,596,379.46 |
| Owner's Equity（Stockholder's Equity） |
57,246,663,048.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
127,651,062,456.68 |
